The Europe subcutaneous immunoglobulin (SCIG) sector is experiencing accelerated growth due to rising awareness of primary immunodeficiency diseases (PIDs), increasing preference for home-based therapy, and advancements in biologics. Valued at USD 2.5 billion in 2024, the sector is projected to grow at a CAGR of 9.0% from 2025 to 2034, reaching USD 5.9 billion by 2034....

Market Overview Orphan drugs refer to pharmaceutical products developed specifically to treat rare medical conditions, also known as orphan diseases. In many regions, a rare disease is defined as one affecting fewer than 200,000 people. These drugs often cater to small patient populations, making them economically less attractive for traditional drug manufacturers. However, with governments...

Polaris Market Research has published a brand-new report titled Paresthesia Treatment Market Share, Size, Trends, Industry Analysis Report, By Type (Acute Paresthesia, Chronic Paresthesia); By Treatment; By End-User; By Region; Segment Forecast, 2023 – 2032 that includes extensive information and analysis of the industry dynamics. The opportunities and challenges in the report's...